Clinical Trial

BCW-Based Resistance Training for Community-Dwelling Sarcopenia Patients

Study acronym: BCW-RES
Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
The study was withdrawn before enrollment because the planned community health service center did not approve the implementation of the intervention, and no participants had been recruited.
Summary
The purpose of this randomized controlled trial is to evaluate the effects of a Behavior Change Wheel (BCW)-based resistance exercise program on muscle health, physical performance, and exercise adherence in community-dwelling older adults with sarcopenia. Participants will be randomly assigned to either an experimental group or a waitlist control group. The experimental group will receive a 12-week BCW-based resistance exercise intervention (twice a week) immediately. The waitlist control group will maintain their usual routine for the first 3 months for comparison, and will then cross over to receive the identical 12-week intervention. The study aims to provide an effective and ethical exercise management strategy for sarcopenic patients.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Withdrawn 2026-07-10
notable Enrollment reduced: 100 -> 0 participants 2026-07-10
notable Enrollment increased: 90 -> 100 participants 2026-06-11
Trial Details
NCT Number NCT07601321
Lead Sponsor Hangzhou Normal University
Conditions Sarcopenia
Start Date 2026-06
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-09